> top > docs > PMC:1189074 > spans > 2890-3315 > annotations

PMC:1189074 / 2890-3315 JSONTXT

Annnotations TAB JSON ListView MergeView

craft-sa-dev

Id Subject Object Predicate Lexical cue
T521 0-4 NN denotes MCAD
T522 5-13 NN denotes activity
T523 14-16 VBZ denotes is
T524 17-26 JJ denotes essential
T525 27-30 IN denotes for
T526 31-39 JJ denotes complete
T527 51-60 NN denotes oxidation
T528 40-45 JJ denotes fatty
T529 46-50 NN denotes acid
T530 60-61 . denotes .
T531 61-140 sentence denotes Inherited MCAD deficiency exists in humans as an autosomal recessive disorder.
T532 62-71 VBN denotes Inherited
T533 77-87 NN denotes deficiency
T534 72-76 NN denotes MCAD
T535 88-94 VBZ denotes exists
T536 95-97 IN denotes in
T537 98-104 NNS denotes humans
T538 105-107 IN denotes as
T539 108-110 DT denotes an
T540 131-139 NN denotes disorder
T541 111-120 JJ denotes autosomal
T542 121-130 JJ denotes recessive
T543 139-140 . denotes .
T544 140-249 sentence denotes MCAD deficiency was first described in 1982—1983 [5–7] and has been described in numerous patients [1,8–11].
T545 141-145 NN denotes MCAD
T546 146-156 NN denotes deficiency
T547 167-176 VBN denotes described
T548 157-160 VBD denotes was
T549 161-166 RB denotes first
T550 177-179 IN denotes in
T551 180-184 CD denotes 1982
T552 184-185 SYM denotes
T553 185-189 CD denotes 1983
T554 190-191 -LRB- denotes [
T555 191-192 CD denotes 5
T556 192-193 SYM denotes
T557 193-194 CD denotes 7
T558 194-195 -RRB- denotes ]
T559 196-199 CC denotes and
T560 200-203 VBZ denotes has
T561 209-218 VBN denotes described
T562 204-208 VBN denotes been
T563 219-221 IN denotes in
T564 222-230 JJ denotes numerous
T565 231-239 NNS denotes patients
T566 240-241 -LRB- denotes [
T567 241-242 CD denotes 1
T568 242-243 , denotes ,
T569 243-244 CD denotes 8
T570 244-245 SYM denotes
T571 245-247 CD denotes 11
T572 247-248 -RRB- denotes ]
T573 248-249 . denotes .
T574 249-425 sentence denotes The carrier frequency in the Caucasian population has been estimated to be between 1 in 50 to 80 with an incidence of clinical disease expected at around 1 in 15,000 [1,9,12].
T575 250-253 DT denotes The
T576 262-271 NN denotes frequency
T577 254-261 NN denotes carrier
T578 309-318 VBN denotes estimated
T579 272-274 IN denotes in
T580 275-278 DT denotes the
T581 289-299 NN denotes population
T582 279-288 JJ denotes Caucasian
T583 300-303 VBZ denotes has
T584 304-308 VBN denotes been
T585 319-321 TO denotes to
T586 322-324 VB denotes be
T587 325-332 IN denotes between
T588 344-346 CD denotes 80
T589 333-334 CD denotes 1
T590 335-337 IN denotes in
T591 338-340 CD denotes 50
T592 341-343 IN denotes to
T593 347-351 IN denotes with
T594 352-354 DT denotes an
T595 355-364 NN denotes incidence
T596 365-367 IN denotes of
T597 368-376 JJ denotes clinical
T598 377-384 NN denotes disease
T599 385-393 VBN denotes expected
T600 394-396 IN denotes at
T601 397-403 IN denotes around
T602 404-405 CD denotes 1
T603 409-415 CD denotes 15,000
T604 406-408 IN denotes in
T605 416-417 -LRB- denotes [
T606 421-423 CD denotes 12
T607 417-418 CD denotes 1
T608 418-419 , denotes ,
T609 419-420 CD denotes 9
T610 420-421 , denotes ,
T611 423-424 -RRB- denotes ]
T612 424-425 . denotes .
R317 T521 T522 compound MCAD,activity
R318 T522 T523 nsubj activity,is
R319 T524 T523 acomp essential,is
R320 T525 T524 prep for,essential
R321 T526 T527 amod complete,oxidation
R322 T527 T525 pobj oxidation,for
R323 T528 T529 amod fatty,acid
R324 T529 T527 compound acid,oxidation
R325 T530 T523 punct .,is
R326 T532 T533 amod Inherited,deficiency
R327 T533 T535 nsubj deficiency,exists
R328 T534 T533 compound MCAD,deficiency
R329 T536 T535 prep in,exists
R330 T537 T536 pobj humans,in
R331 T538 T535 prep as,exists
R332 T539 T540 det an,disorder
R333 T540 T538 pobj disorder,as
R334 T541 T540 amod autosomal,disorder
R335 T542 T540 amod recessive,disorder
R336 T543 T535 punct .,exists
R337 T545 T546 compound MCAD,deficiency
R338 T546 T547 nsubjpass deficiency,described
R339 T548 T547 auxpass was,described
R340 T549 T547 advmod first,described
R341 T550 T547 prep in,described
R342 T551 T550 pobj 1982,in
R343 T552 T553 punct —,1983
R344 T553 T551 prep 1983,1982
R345 T554 T555 punct [,5
R346 T555 T547 parataxis 5,described
R347 T556 T557 punct –,7
R348 T557 T555 prep 7,5
R349 T558 T555 punct ],5
R350 T559 T547 cc and,described
R351 T560 T561 aux has,described
R352 T561 T547 conj described,described
R353 T562 T561 auxpass been,described
R354 T563 T561 prep in,described
R355 T564 T565 amod numerous,patients
R356 T565 T563 pobj patients,in
R357 T566 T567 punct [,1
R358 T567 T561 parataxis 1,described
R359 T568 T567 punct ",",1
R360 T569 T567 appos 8,1
R361 T570 T571 punct –,11
R362 T571 T569 prep 11,8
R363 T572 T567 punct ],1
R364 T573 T547 punct .,described
R365 T575 T576 det The,frequency
R366 T576 T578 nsubjpass frequency,estimated
R367 T577 T576 compound carrier,frequency
R368 T579 T576 prep in,frequency
R369 T580 T581 det the,population
R370 T581 T579 pobj population,in
R371 T582 T581 amod Caucasian,population
R372 T583 T578 aux has,estimated
R373 T584 T578 auxpass been,estimated
R374 T585 T586 aux to,be
R375 T586 T578 xcomp be,estimated
R376 T587 T588 quantmod between,80
R377 T588 T586 attr 80,be
R378 T589 T588 quantmod 1,80
R379 T590 T588 quantmod in,80
R380 T591 T588 quantmod 50,80
R381 T592 T588 quantmod to,80
R382 T593 T586 prep with,be
R383 T594 T595 det an,incidence
R384 T595 T593 pobj incidence,with
R385 T596 T595 prep of,incidence
R386 T597 T598 amod clinical,disease
R387 T598 T596 pobj disease,of
R388 T599 T598 acl expected,disease
R389 T600 T599 prep at,expected
R390 T601 T602 quantmod around,1
R391 T602 T603 nummod 1,"15,000"
R392 T603 T600 pobj "15,000",at
R393 T604 T602 quantmod in,1
R394 T605 T606 punct [,12
R395 T606 T586 parataxis 12,be
R396 T607 T606 nummod 1,12
R397 T608 T606 punct ",",12
R398 T609 T606 nummod 9,12
R399 T610 T606 punct ",",12
R400 T611 T606 punct ],12
R401 T612 T578 punct .,estimated

craft-ca-core-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T821 40-50 CHEBI:35366 denotes fatty acid
T822 40-60 GO:0019395 denotes fatty acid oxidation
T823 51-60 MOP:0000568 denotes oxidation
T824 98-104 NCBITaxon:9606 denotes humans
T825 111-120 GO:0030849 denotes autosomal

2_test

Id Subject Object Predicate Lexical cue
16121256-7172449-86078320 191-192 7172449 denotes 5
16121256-11826276-86078321 241-242 11826276 denotes 1
16121256-1438385-86078322 243-244 1438385 denotes 8
16121256-1601002-86078322 243-244 1601002 denotes 8
16121256-11826276-86078323 417-418 11826276 denotes 1
16121256-1601002-86078324 419-420 1601002 denotes 9
T83102 191-192 7172449 denotes 5
T12275 241-242 11826276 denotes 1
T87677 243-244 1438385 denotes 8
T56847 243-244 1601002 denotes 8
T46683 417-418 11826276 denotes 1
T65133 419-420 1601002 denotes 9

craft-ca-core-ex-dev

Below, discontinuous spans are shown in the chain model. You can change it to the bag model.

Id Subject Object Predicate Lexical cue
T876 0-4 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T877 40-45 CHEBI_UBERON_EXT:triglyceride_or_adipose_tissue denotes fatty
T878 40-50 CHEBI:35366 denotes fatty acid
T879 40-60 GO:0019395 denotes fatty acid oxidation
T880 51-60 MOP:0000568 denotes oxidation
T881 72-76 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD
T882 98-104 NCBITaxon:9606 denotes humans
T883 111-120 GO:0030849 denotes autosomal
T884 141-145 GO_PR_EXT:medium_chain_acyl_CoA_dehydrogenase denotes MCAD